Novartis AG — Director's Dealing 2012

Sep 25, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK: 0001178670
Period of Report: 2012-09-20

Reporting Person: NOVARTIS AG (10% Owner)
Reporting Person: NOVARTIS PHARMA AG (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-09-20	Common Stock	S	1551896	$19.42	Disposed	4051002	Indirect

Footnotes

F1: These securities are owned directly by Novartis Pharma AG, a direct, wholly-owned subsidiary of Novartis AG. Novartis AG is an indirect beneficial owner of these securities.